Fletcher Spaght Ventures

Fletcher Spaght Ventures

A venture capital and private equity firm investing in healthcare, life science, and information technology companies.

Fletcher Spaght Ventures is a venture capital and private equity firm investing in healthcare, life science, and information technology companies that is headquartered in Boston, Massachusetts and was founded in 2001 by John Fletcher and Linda Tufts.

Investments

As of December 2019, Fletcher Spaght Ventures has made 37 investments, has 9 companies in its portfolio, and made a total of 19 exits. Notable investments made by Fletcher Spaght Ventures include: PhaseBio Pharmaceuticals, Swift Biosciences, HTG Molecular Diagnostics, Cadent, Biocius Life Sciences, HistoSonics, CardioFocus, Cheetah Medical, SurgiQuest, Cayenne Medical, and BioTrove.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Juventus Therapeutics

Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.

Biotechnology
Cleveland
Metabolon

A company developing metabolomics analytical methods and software for biomarker discovery

Biotechnology
North Carolina
Htg Molecular Diagnostics

A diagnostics company developing automated sample processing

Biotechnology
Tucson, Arizona
PhaseBio Pharmaceuticals

A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders

Biotechnology
Malvern, Arkansas
SurgiQuest

SurgiQuest is a healthcare company.

Healthcare
Cheetah Medical

SironRX Therapeutics

7 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.